These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15824899)

  • 41. Partial pathogen protection by tick-bite sensitization and epitope recognition in peptide-immunized HLA DR3 transgenic mice.
    Shattuck WM; Dyer MC; Desrosiers J; Fast LD; Terry FE; Martin WD; Moise L; De Groot AS; Mather TN
    Hum Vaccin Immunother; 2014; 10(10):3048-59. PubMed ID: 25517089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and characterization of Ixodes scapularis antigens that elicit tick immunity using yeast surface display.
    Schuijt TJ; Narasimhan S; Daffre S; DePonte K; Hovius JW; Van't Veer C; van der Poll T; Bakhtiari K; Meijers JC; Boder ET; van Dam AP; Fikrig E
    PLoS One; 2011 Jan; 6(1):e15926. PubMed ID: 21246036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disruption of Ixodes scapularis anticoagulation by using RNA interference.
    Narasimhan S; Montgomery RR; DePonte K; Tschudi C; Marcantonio N; Anderson JF; Sauer JR; Cappello M; Kantor FS; Fikrig E
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1141-6. PubMed ID: 14745044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Roadmap for Tick-Borne Flavivirus Research in the "Omics" Era.
    Grabowski JM; Hill CA
    Front Cell Infect Microbiol; 2017; 7():519. PubMed ID: 29312896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ixodes scapularis saliva components that elicit responses associated with acquired tick-resistance.
    Narasimhan S; Kurokawa C; Diktas H; Strank NO; Černý J; Murfin K; Cao Y; Lynn G; Trentleman J; Wu MJ; DePonte K; Kantor F; Anguita J; Hovius J; Fikrig E
    Ticks Tick Borne Dis; 2020 May; 11(3):101369. PubMed ID: 31924502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defining the role of subolesin in tick cell culture by use of RNA interference.
    Blouin EF; Manzano-Roman R; de la Fuente J; Kocan KM
    Ann N Y Acad Sci; 2008 Dec; 1149():41-4. PubMed ID: 19120170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseases.
    Lew-Tabor AE; Rodriguez Valle M
    Ticks Tick Borne Dis; 2016 Jun; 7(4):573-85. PubMed ID: 26723274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting a global health problem: Vaccine design and challenges for the control of tick-borne diseases.
    de la Fuente J; Contreras M; Estrada-Peña A; Cabezas-Cruz A
    Vaccine; 2017 Sep; 35(38):5089-5094. PubMed ID: 28780117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fractionation of tick saliva reveals proteins associated with the development of acquired resistance to Ixodes scapularis.
    Černý J; Lynn G; DePonte K; Ledizet M; Narasimhan S; Fikrig E
    Vaccine; 2020 Dec; 38(51):8121-8129. PubMed ID: 33168347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunology of the tick-host interaction and the control of ticks and tick-borne diseases.
    Willadsen P; Jongejan F
    Parasitol Today; 1999 Jul; 15(7):258-62. PubMed ID: 10377526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting arthropod subolesin/akirin for the development of a universal vaccine for control of vector infestations and pathogen transmission.
    de la Fuente J; Moreno-Cid JA; Canales M; Villar M; de la Lastra JM; Kocan KM; Galindo RC; Almazán C; Blouin EF
    Vet Parasitol; 2011 Sep; 181(1):17-22. PubMed ID: 21561715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of ferritin 2 for the control of tick infestations.
    Hajdusek O; Almazán C; Loosova G; Villar M; Canales M; Grubhoffer L; Kopacek P; de la Fuente J
    Vaccine; 2010 Apr; 28(17):2993-8. PubMed ID: 20171306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of vaccines against Ornithodoros soft ticks: An update.
    Díaz-Martín V; Manzano-Román R; Obolo-Mvoulouga P; Oleaga A; Pérez-Sánchez R
    Ticks Tick Borne Dis; 2015 Apr; 6(3):211-20. PubMed ID: 25802033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upcoming and future strategies of tick control: a review.
    Ghosh S; Azhahianambi P; Yadav MP
    J Vector Borne Dis; 2007 Jun; 44(2):79-89. PubMed ID: 17722860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.
    Sprong H; Trentelman J; Seemann I; Grubhoffer L; Rego RO; Hajdušek O; Kopáček P; Šíma R; Nijhof AM; Anguita J; Winter P; Rotter B; Havlíková S; Klempa B; Schetters TP; Hovius JW
    Parasit Vectors; 2014 Feb; 7():77. PubMed ID: 24559082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential expression of the tick protective antigen subolesin in anaplasma marginale- and A. phagocytophilum-infected host cells.
    de la Fuente J; Blouin EF; Manzano-Roman R; Naranjo V; Almazán C; Pérez de la Lastra JM; Zivkovic Z; Massung RF; Jongejan F; Kocan KM
    Ann N Y Acad Sci; 2008 Dec; 1149():27-35. PubMed ID: 19120168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting the tick protective antigen subolesin reduces vector infestations and pathogen infection by Anaplasma marginale and Babesia bigemina.
    Merino O; Almazán C; Canales M; Villar M; Moreno-Cid JA; Galindo RC; de la Fuente J
    Vaccine; 2011 Nov; 29(47):8575-9. PubMed ID: 21951878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlling ticks and tick-borne diseases…looking forward.
    de la Fuente J
    Ticks Tick Borne Dis; 2018 Jul; 9(5):1354-1357. PubMed ID: 29656834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tick Bioactive Molecules as Novel Therapeutics: Beyond Vaccine Targets.
    Murfin KE; Fikrig E
    Front Cell Infect Microbiol; 2017; 7():222. PubMed ID: 28634573
    [No Abstract]   [Full Text] [Related]  

  • 60. Anti-Tick Vaccines: Current Advances and Future Prospects.
    Muhanguzi D; Ndekezi C; Nkamwesiga J; Kalayou S; Ochwo S; Vuyani M; Kimuda MP
    Methods Mol Biol; 2022; 2411():253-267. PubMed ID: 34816410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.